Riccardo Leone

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Cerebrospinal Fluid

Magnetic Resonance

Diffuse Large B Cell Lymphoma

Top Venues

Bioengineering (Basel, Switzerland)

Neuro-oncology advances

This page only lists publications with an associated author ORCID identifier.

Publications

Michela Destito, Aldo Marzullo, Riccardo Leone, Paolo Zaffino, Sara Steffanoni, Federico Erbella, Francesco Calimeri, Nicoletta Anzalone, Elena De Momi, Andrés José Maria Ferreri, Teresa Calimeri, Maria Francesca Spadea
Radiomics-Based Machine Learning Model for Predicting Overall and Progression-Free Survival in Rare Cancer: A Case Study for Primary CNS Lymphoma Patients. Bioengineering (Basel, Switzerland) 10 (3) (2023)
Riccardo Leone, Hagen Meredig, Martha Foltyn-Dumitru, Felix Sahm, Stefan Hamelmann, Felix Kurz, Tobias Kessler, David Bonekamp, Heinz-Peter Schlemmer, Mikkel Bo Hansen, Wolfgang Wick, Martin Bendszus, Philipp Vollmuth, Gianluca Brugnara
Assessing the added value of apparent diffusion coefficient, cerebral blood volume, and radiomic magnetic resonance features for differentiation of pseudoprogression versus true tumor progression in patients with glioblastoma. Neuro-oncology advances 5 (1) (2023)
Riccardo Leone, Hagen Meredig, Martha Foltyn-Dumitru, Felix Sahm, Stefan Hamelmann, Felix Kurz, Tobias Kessler, David Bonekamp, Heinz-Peter Schlemmer, Mikkel Bo Hansen, Wolfgang Wick, Martin Bendszus, Philipp Vollmuth, Gianluca Brugnara
Assessing the added value of apparent diffusion coefficient, cerebral blood volume, and radiomic magnetic resonance features for differentiation of pseudoprogression versus true tumor progression in patients with glioblastoma. Neuro-oncology advances 5 (1) (2023)
Michela Destito, Aldo Marzullo, Riccardo Leone, Paolo Zaffino, Sara Steffanoni, Federico Erbella, Francesco Calimeri, Nicoletta Anzalone, Elena De Momi, Andrés José Maria Ferreri, Teresa Calimeri, Maria Francesca Spadea
Radiomics-Based Machine Learning Model for Predicting Overall and Progression-Free Survival in Rare Cancer: A Case Study for Primary CNS Lymphoma Patients. Bioengineering (Basel, Switzerland) 10 (3) (2023)